DISTRIBUTION OF CAPSULAR TYPES AND PENICILLIN-RESISTANCE OF STRAINS OF STREPTOCOCCUS-PNEUMONIAE CAUSING SYSTEMIC INFECTIONS IN ARGENTINEAN CHILDREN UNDER 5 YEARS OF AGE

Citation
A. Rossi et al., DISTRIBUTION OF CAPSULAR TYPES AND PENICILLIN-RESISTANCE OF STRAINS OF STREPTOCOCCUS-PNEUMONIAE CAUSING SYSTEMIC INFECTIONS IN ARGENTINEAN CHILDREN UNDER 5 YEARS OF AGE, Microbial drug resistance, 3(2), 1997, pp. 135-140
Citations number
31
Categorie Soggetti
Microbiology,"Infectious Diseases
Journal title
ISSN journal
10766294
Volume
3
Issue
2
Year of publication
1997
Pages
135 - 140
Database
ISI
SICI code
1076-6294(1997)3:2<135:DOCTAP>2.0.ZU;2-2
Abstract
Streptococcus pneumoniae (SPN) is the most common cause of invasive in fections in children, with high levels of mortality in developing coun tries, An increase in frequency of penicillin-resistant strains is rep orted in most parts of the world, A study was undertaken in Argentina and 5 other countries of the region, to determine the type distributio n and penicillin resistance rate of SPN isolated from invasive infecti ons in children less than 5 years old. Between June 1994 and March 199 6, a total of 505 SPN isolated from sterile sites were collected from 15 hospitals located in 9 cities of different geographic areas, Clinic al and epidemiological data from 443 children were analyzed. Sixty fiv e percent SPN were isolated from children less than 2 years old, Pneum onia was the clinical diagnosis in 58% of the cases, meningitis in 22% , and sepsis in 10.6%. Isolates were recovered from blood (51.2%), ple ural fluid (22.7%), CSF (20.7%), and other sterile sites (5.4%). Thirt y different pneumococcal capsular types were identified and the 10 mos t frequent in descending order were: 14, 5, 1, 6A/6B, 7F, 9V, 19F, 19A , 16F y 23F, representing 89.3% of the total, Overall, 13.1% of isolat es showed intermediate resistance to penicillin while 11.3% showed hig h resistance, Lethality was 8.8%, without correlation with penicillin- resistance and/or type, These result should be used in selecting the o ptimal combination of specific types for a conjugate vaccine, useful i n children less than 2 years old and for considering therapeutic strat egies for invasive pneumococcal infections.